Company intelligence / Profile preview

Lyphe Dispensary

London, United Kingdom

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Lyphe Dispensary is a leading UK-based medical cannabis pharmacy and a core component of the Lyphe Group ecosystem. The company specializes in the fulfillment of medical cannabis prescriptions, providing patients with access to a wide range of flower, oil, and capsule formulations. By integrating telehealth clinical services with specialized dispensing, Lyphe Dispensary streamlines the patient journey from consultation to medication delivery. The company operates under strict regulatory oversight from the General Pharmaceutical Council (GPhC) to ensure high standards of patient care and product quality.

Therapeutic areas: PsychiatryNeurology
Modalities: Small moleculePlant extractBotanical extract
Industry: Non-Academic Healthcare

Partnerships

CuraleafAurora CannabisTilrayAdven

Beyond the preview

Go deeper on Lyphe Dispensary.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lyphe Dispensary.

Explore the full profile